An investigation into fused filament fabrication for pharmaceutical manufacturing

Elanor M. Brammer, Gavin W. Halbert, Dimitrios A. Lamprou

Research output: Contribution to conferencePoster

38 Downloads (Pure)

Abstract

In a modern world, what is the best way to deliver medicines to the patient? Human beings are an extremely diverse species with many different factors that can influence the behaviour of a drug within the body. Children are a perfect example of such variety. Doses are often prescribed based on body weight, and can vary greatly from infants to adolescents. With current ‘traditional’ manufacture of oral dose pharmaceuticals, generally only a limited number of doses are produced, leading to difficulties with appropriate dosing. The ability to manufacture personalised doses for these patients would be of great benefit both practically and financially, and may even lead to ‘point of care’ manufacture.
Original languageEnglish
Publication statusUnpublished - 7 Apr 2016
EventPBP 10th World Meeting in Pharmaceutics, Biopharmeceutics and Pharmaceutical Technology - SECC, Glasgow, United Kingdom
Duration: 4 Apr 20167 Apr 2016

Conference

ConferencePBP 10th World Meeting in Pharmaceutics, Biopharmeceutics and Pharmaceutical Technology
CountryUnited Kingdom
CityGlasgow
Period4/04/167/04/16

Keywords

  • pharmaceutical manufacturing
  • drug delivery
  • fused filament fabrication (FFF)
  • 3D tablets

Cite this